daewoong gliatamin cdmo
Scope
Date
~
-
Bio & Pharma
Celltrion earmarks billions of dollars to build CDMO plant: chairman
Celltrion Inc., South Korea’s largest biosimilar maker, will spend several billion dollars to build a factory to crack the contract developmen...
Sep 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion chairman announces venture into CDMO market
South Korea’s biosimilar maker Celltrion Inc. will venture into the contract development and manufacturing organization (CDMO) market, the com...
Sep 09, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte to restructure bio business to focus on CDMO
South Korea’s retail-to-chemical conglomerate Lotte Group will restructure its bio business to focus on the profit-making medicine bio develop...
Sep 09, 2024 (Gmt+09:00)
-
Bio & Pharma
Daewoong wins permission for Nabota in Argentina
South Korea's Daewoong Pharmaceutical Co. announced on Monday that its botulinum toxin Nabota received product approval from Argentina's National Ad...
Jul 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Daewoong, Indonesia's IPB to co-research on primate
South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it signed a contract with Indonesia's Bogor Agricultural University (Institut P...
Jun 27, 2024 (Gmt+09:00)
-
Corporate restructuring
SK Inc. in talks to sell Pharmteco’s US CDMO plant to Novo Nordisk
SK Inc., the holding and investment company of SK Group, South Korea’s second-largest conglomerate, is negotiating to sell a major asset of it...
Jun 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics eyes windfall gain amid US-China row
SAN DIEGO – Samsung Biologics Co. is enjoying a stream of contract development and manufacturing order inquiries from big pharmaceutical compa...
Jun 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharmaceutical digitizes DB of 800 mn chemical compounds
South Korea's Daewoong Pharmaceutical announced on Monday that it has established a drug development system Daewoong AI System (DAISY) which combine...
Feb 19, 2024 (Gmt+09:00)
-
Bio & Pharma
Daewoong gets stem cell facility license in Indonesia
South Korea's Daewoong Pharmaceutical announced on Tuesday that its subsidiary Daewoong Biologics Indonesia has obtained a stem cell Lab Operational...
Feb 13, 2024 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s GC Cell targets global cell therapy CDMO business
GC Cell Corp., an affiliate of South Korea’s major pharmaceutical company GC Biopharma Corp., is targeting the cell therapy contract developme...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong exports $92.4 mn Depot injection tech to UAE
South Korea's Daewoong Pharmaceutical announced on Monday that it exported its technology for clinical development and commercialization rights of i...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharm set to export Envlo Tab to Russia, CIS
Daewoong Pharmaceutical, a leading South Korean pharmaceutical company will export its new diabetes drug Envlo Tab. (active ingredient:enavogliflozi...
Dec 01, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco launches new viral vector platforms, key for CGT
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has recently introduced two...
Nov 22, 2023 (Gmt+09:00)
-
Bio & Pharma
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...
Nov 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Merck team up for AI tech for new drug
South Korea's Daewoong Pharmaceutical announced on Tuesday it signed with memorandum of understanding (MOU) with Merck Life Science to build an arti...
Oct 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma's GER drug gets product OK from Mexico
South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan ...
Oct 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics to break ground on 1st local CDMO plant in 2024
South Korea’s Lotte Biologics Co. is set to start building its first local facility for drug manufacturing next year, aiming for 400,000 liter...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biologics partners with Indian company for CDMO
Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, is expanding its CDMO b...
Sep 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong to develop eye drops for diabetic retinopathy
South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...
Sep 15, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
IMM PE invites potential buyers for Genuone worth $752 mn
South Korea’s top-tier contract drugmaker Genuone Sciences Inc. with an estimated value of up to 1 trillion won ($752 million) is smooth saili...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong gets patent of Nabota as migraine drug in US
South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it has received a patent from the US Patent and Trademark Office for the use of...
Sep 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong applies for approval of Envlo in Saudi Arabia
South Korea's Daewoong Pharmaceutical Co. announced on Friday that it has submitted an application for regulatory approval of its new diabetes treat...
Aug 25, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco gears up for big leap in advanced biotherapies
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is upping the ante in its b...
Aug 17, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience buys 6.5 million Novavax shares for $83.4 million
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...
Aug 09, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco secures 12 global pharma clients, sets up US R&D center
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has secured 12 global pharm...
Aug 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong launches GERD treatment Fexuclu in Philippines
South Korea's Daewoong Pharmaceutical announced on Tuesday that it has launched the GERD treatment drug "Fexuclue" (active ingredient: Fexuprazan) i...
Aug 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong's Nabota exceeds 600,000 customers in US
South Korea's Daewoong Pharmaceutical said on Thursday that its local loyalty program for Nabota (American name: Jeuveau) in the US, a botulinum tox...
Jul 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics, Pfizer sign $411.3 mn agreement for long-term CDMO
Samsung Biologics Co., the world’s No. 1 contract drugmaker, announced a groundbreaking strategic partnership with Pfizer on Thursday, marking...
Jun 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics to double production by 2032; eyes ADCs, M&As
BOSTON – Samsung Biologics Co., the world’s No. 1 contract drugmaker, plans to more than double its total annual production capacity to ...
Jun 07, 2023 (Gmt+09:00)
-
Bio & Pharma
BIO USA 2023 to draw S.Korean biotech leaders, startups
More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...
May 30, 2023 (Gmt+09:00)
Latest News
- 1 Hyundai, Waymo forge multi-year, strategic partnership for self-driving vehicles
- 2 AI startup MarqVision raises $16.5 mn to close Series A
- 3 Taihan Cable wins $630 mn power grid project in Singapore
- 4 Korean startup scene is gloomy, say 2 out of 5 startup CEOs
- 5 MBK ups stakes for Korea Zinc to match buyback offer